Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pig liver bandage shows promise for stubborn wounds in small new study

NCT ID NCT06939673

Disease control Sponsor: Reprise Biomedical, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a wound dressing called Miro3D, made from pig liver tissue, to see if it helps heal hard-to-treat wounds like diabetic foot ulcers and pressure ulcers. Up to 20 adults will receive the dressing along with standard care for up to 12 weeks. Researchers will measure wound shrinkage, new tissue growth, and changes in quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 or older and able to provide informed consent. 2. Has an open wound or ulceration, preferably with tunneling or undermining. 3. If multiple wounds/ulcerations are present, only one will be selected for Miro3D treatment. 4. Other wounds must be ≥2 cm away from the study wound. 5. Wound should be debrided with a clinical goal of healing, even if some infection remains. 6. Previous infections must be adequately treated and controlled (per IDSA guidelines). 7. Willing and able to comply with offloading and/or compression requirements. 8. Must have a stable living environment for wound care adherence. 9. Study wound must have a clean base free of devitalized tissue or debris at the time of Miro3D placement. 10. Provides consent for digital photo documentation. Exclusion Criteria: 1. Active, untreated osteomyelitis. 2. Malignancy or vasculitis at the wound site. 3. Undergoing chemotherapy. 4. On dialysis. 5. Use of investigational drugs or therapies within 30 days before screening. 6. Conditions that significantly impair study adherence or known history of medical non-compliance. 7. Known sensitivity to porcine materials. 8. Third-degree burns. 9. Worsening ischemia or gangrene at screening. 10. Prior radiation to the study wound site. 11. Exposed hardware, implants, or fixation devices in the study wound. 12. Receiving palliative or comfort care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic wound are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic ulcer of skin decubitus ulcer Diabetic Foot Surgical Wound Dehiscence ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic wounds Diabetic foot ulcers (DFUS) Pressure ulcers Surgical wound dehiscence (SWD) Undermined and tunneling wounds Venous leg ulcers (VLUS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Barry University Clinical Research

    RECRUITING

    Tamarac, Florida, 33321, United States

  • West Boca Center for Wound Healing

    NOT_YET_RECRUITING

    Coconut Creek, Florida, 33073, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.